3' end formation of pre-mRNA and phosphorylation of Ser2 on the RNA polymerase II CTD are reciprocally coupled in human cells

Genes and Development

Volumn 28, Issue 4, 2014, Pages 342-356

  Davidson, Lee ^a   Muniz, Lisa ^a   West, Steven ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

C terminal domain; Cdk12; Cleavage and polyadenylation; Pausing; RNA polymerase II; Ser2

Indexed keywords

C-TERMINAL DOMAIN; CDK12; CLEAVAGE AND POLYADENYLATION; PAUSING; RNA POLYMERASE II; SER2;

CYCLIN-DEPENDENT KINASES; GENE EXPRESSION REGULATION; HUMANS; PHOSPHORYLATION; PROTEIN STRUCTURE, TERTIARY; RNA POLYMERASE II; RNA PRECURSORS; SERINE;

EID: 84893936668     PISSN: 08909369     EISSN: 15495477     Source Type: Journal    
DOI: 10.1101/gad.231274.113     Document Type: Article

References (59)

1. Ahn SH, Kim M, Buratowski S. 2004. Phosphorylation of serine 2 within the RNA polymerase II C-terminal domain couples transcription and 39 end processing. Mol Cell 13: 67-76.
2. Anamika K, Gyenis A, Poidevin L, Poch O, Tora L. 2012. RNA polymerase II pausing downstream of core histone genes is different from genes producing polyadenylated transcripts. PLo S ONE 7: e38769.
3. Bartkowiak B, Liu P, Phatnani HP, Fuda NJ, Cooper JJ, Price DH, Adelman K, Lis JT, Greenleaf AL. 2010. CDK12 is a transcription elongation-associated CTD kinase, the metazoan ortholog of yeast Ctk1. Genes Dev 24: 2303-2316.
4. Bataille AR, Jeronimo C, Jacques PE, Laramee L, Fortin ME, Forest A, Bergeron M, Hanes SD, Robert F. 2012. A universal RNA polymerase II CTD cycle is orchestrated by complex interplays between kinase, phosphatase, and isomerase enzymes along genes. Mol Cell 45: 158-170.
5. Berg MG, Singh LN, Younis I, Liu Q, Pinto AM, Kaida D, Zhang Z, Cho S, Sherrill-Mix S, Wan L, et al. 2012. U1 snRNP determines mRNA length and regulates isoform expression. Cell 150: 53-64.
6. Bieberstein NI, Oesterreich FC, Straube K, Neugebauer KM. 2012. First exon length controls active chromatin signatures and transcription. Cell Rep 2: 62-68.
7. Blazek D, Kohoutek J, Bartholomeeusen K, Johansen E, Hulinkova P, Luo Z, Cimermancic P, Ule J, Peterlin BM. 2011. The Cyclin K/Cdk12 complex maintains genomic stability via regulation of expression of DNA damage response genes. Genes Dev 25: 2158-2172.
8. Brookes E, de Santiago I, Hebenstreit D, Morris KJ, Carroll T, Xie SQ, Stock JK, Heidemann M, Eick D, Nozaki N, et al. 2012. Polycomb associates genome-wide with a specific RNA polymerase II variant, and regulates metabolic genes in ESCs. Cell Stem Cell 10: 157-170.
9. Buratowski S. 2009. Progression through the RNA polymerase II CTD cycle. Mol Cell 36: 541-546.
10. Chapman RD, Heidemann M, Albert TK, Mailhammer R, Flatley A, Meisterernst M, Kremmer E, Eick D. 2007. Transcribing RNA polymerase II is phosphorylated at CTD residue serine-7. Science 318: 1780-1782.
11. Cho EJ, Kobor MS, Kim M, Greenblatt J, Buratowski S. 2001. Opposing effects of Ctk1 kinase and Fcp1 phosphatase at Ser 2 of the RNA polymerase II C-terminal domain. Genes Dev 15: 3319-3329.
12. Cong L, Ran FA, Cox D, Lin S, Barretto R, Habib N, Hsu PD, Wu X, Jiang W, Marraffini LA, et al. 2013. Multiplex genome engineering using CRISPR/Cas systems. Science 339: 819-823.
13. Dantonel JC, Murthy KG, Manley JL, Tora L. 1997. Transcription factor TFIID recruits factor CPSF for formation of 39 end of mRNA. Nature 389: 399-402.
14. Davidson L, West S. 2013. Splicing-coupled 39 end formation requires a terminal splice acceptor site, but not intron excision. Nucleic Acids Res 41: 7101-7114.
15. Davidson L, Kerr A, West S. 2012. Co-transcriptional degradation of aberrant pre-mRNA by Xrn2. EMBO J 31: 2566-2578.
16. de Almeida SF, Grosso AR, Koch F, Fenouil R, Carvalho S, Andrade J, Levezinho H, Gut M, Eick D, Gut I, et al. 2011. Splicing enhances recruitment of methyltransferase HYPB/Setd2 and methylation of histone H3 Lys36. Nat Struct Mol Biol 18: 977-983.
17. Devaiah BN, Lewis BA, Cherman N, Hewitt MC, Albrecht BK, Robey PG, Ozato K, Sims RJ 3rd, Singer DS. 2012. BRD4 is an atypical kinase that phosphorylates serine2 of the RNA polymerase II carboxy-terminal domain. Proc Natl Acad Sci 109: 6927-6932.
18. Dominski Z, Yang XC, Purdy M, Wagner EJ, Marzluff WF. 2005. A CPSF-73 homologue is required for cell cycle progression but not cell growth and interacts with a protein having features of CPSF-100. Mol Cell Biol 25: 1489-1500.
19. Dye MJ, Proudfoot NJ. 2001. Multiple transcript cleavage precedes polymerase release in termination by RNA polymerase II. Cell 105: 669-681.
20. Eggermont J, Proudfoot NJ. 1993. Poly(A) signals and transcriptional pause sites combine to prevent interference between RNA polymerase II promoters. EMBO J 12: 2539-2548.
21. Eick D, Geyer M. 2013. The RNA polymerase II carboxyterminal domain code. Chem Rev 113: 8456-8490.
22. Fuda NJ, Buckley MS, Wei W, Core LJ, Waters CT, Reinberg D, Lis JT. 2012. Fcp1 dephosphorylation of the RNA polymerase II C-terminal domain is required for efficient transcription of heat shock genes. Mol Cell Biol 32: 3428-3437.
23. Garrido-Lecca A, Blumenthal T. 2010. RNA polymerase II Cterminal domain phosphorylation patterns in Caenorhabditis elegans operons, polycistronic gene clusters with only one promoter. Mol Cell Biol 30: 3887-3893.
24. Gilbert LA, Larson MH, Morsut L, Liu Z, Brar GA, Torres SE, Stern-Ginossar N, Brandman O, Whitehead EH, Doudna JA, et al. 2013. CRISPR-mediated modular RNA-guided regulation of transcription in eukaryotes. Cell 154: 442-451.
25. Glover-Cutter K, Kim S, Espinosa J, Bentley DL. 2008. RNA polymerase II pauses and associates with pre-mRNA processing factors at both ends of genes. Nat Struct Mol Biol 15: 71-78.
26. Gnatt AL, Cramer P, Fu J, Bushnell DA, Kornberg RD. 2001. Structural basis of transcription: An RNA polymerase II elongation complex at 3.3 A resolution. Science 292: 1876-1882.
27. Gromak N, West S, Proudfoot NJ. 2006. Pause sites promote transcriptional termination of mammalian RNA polymerase II. Mol Cell Biol 26: 3986-3996.
28. Grosso AR, de Almeida SF, Braga J, Carmo-Fonseca M. 2012. Dynamic transitions in RNA polymerase II density profiles during transcription termination. Genome Res 22: 1447-1456.
29. Gu B, Eick D, Bensaude O. 2012. CTD serine-2 plays a critical role in splicing and termination factor recruitment to RNA polymerase II in vivo. Nucleic Acids Res 41: 1591-1603.
30. Hintermair C, Heidemann M, Koch F, Descostes N, Gut M, Gut I, Fenouil R, Ferrier P, Flatley A, Kremmer E, et al. 2012. Threonine-4 of mammalian RNA polymerase II CTD is targeted by Polo-like kinase 3 and required for transcriptional elongation. EMBO J 31: 2784-2797.
31. Kaida D, Berg MG, Younis I, Kasim M, Singh LN, Wan L, Dreyfuss G. 2010. U1 snRNP protects pre-mRNAs from premature cleavage and polyadenylation. Nature 468: 664-668.
32. Kim M, Krogan NJ, Vasiljeva L, Rando OJ, Nedea E, Greenblatt JF, Buratowski S. 2004. The yeast Rat1 exonuclease promotes transcription termination by RNA polymerase II. Nature 432: 517-522.
33. Kim S, Kim H, Fong N, Erickson B, Bentley DL. 2011. Prem RNA splicing is a determinant of histone H3K36 methylation. Proc Natl Acad Sci 108: 13564-13569.
34. Kolev NG, Steitz JA. 2005. Symplekin and multiple other polyadenylation factors participate in 39-end maturation of histone mRNAs. Genes Dev 19: 2583-2592.
35. Komarnitsky P, Cho EJ, Buratowski S. 2000. Different phosphorylated forms of RNA polymerase II and associated mRNA processing factors during transcription. Genes Dev 14: 2452-2460.
36. Luco RF, Pan Q, Tominaga K, Blencowe BJ, Pereira-Smith OM, Misteli T. 2010. Regulation of alternative splicing by histone modifications. Science 327: 996-1000.
37. Mali P, Yang L, Esvelt KM, Aach J, Guell M, Di Carlo JE, Norville JE, Church GM. 2013. RNA-guided human genome engineering via Cas9. Science 339: 823-826.
38. Mandel CR, Kaneko S, Zhang H, Gebauer D, Vethantham V, Manley JL, Tong L. 2006. Polyadenylation factor CPSF-73 is the pre-mRNA 39-end-processing endonuclease. Nature 444: 953-956.
39. Mapendano CK, Lykke-Andersen S, Kjems J, Bertrand E, Jensen TH. 2010. Crosstalk between mRNA 39 end processing and transcription initiation. Mol Cell 40: 410-422.
40. Mayr C, Bartel DP. 2009. Widespread shortening of 39UTRs by alternative cleavage and polyadenylation activates oncogenes in cancer cells. Cell 138: 673-684.
41. McCracken S, Fong N, Yankulov K, Ballantyne S, Pan G, Greenblatt J, Patterson SD, Wickens M, Bentley DL. 1997. The C-terminal domain of RNA polymerase II couples mRNA processing to transcription. Nature 385: 357-361.
42. Nag A, Narsinh K, Martinson HG. 2007. The poly(A)-dependent transcriptional pause is mediated by CPSF acting on the body of the polymerase. Nat Struct Mol Biol 14: 662-669.
43. Nemeroff ME, Barabino SM, Li Y, Keller W, Krug RM. 1998. Influenza virus NS1 protein interacts with the cellular 30 kDa subunit of CPSF and inhibits 39end formation of cellular pre-mRNAs. Mol Cell 1: 991-1000.
44. Orozco IJ, Kim SJ, Martinson HG. 2002. The poly(A) signal, without the assistance of any downstream element, directs RNA polymerase II to pause in vivo and then to release stochastically from the template. J Biol Chem 277: 42899-42911.
45. Osheim YN, Proudfoot NJ, Beyer AL. 1999. EM visualization of transcription by RNA polymerase II: Downstream termination requires a poly(A) signal but not transcript cleavage. Mol Cell 3: 379-387.
46. Osheim YN, Sikes ML, Beyer AL. 2002. EM visualization of Pol II genes in Drosophila: Most genes terminate without prior 39 end cleavage of nascent transcripts. Chromosoma 111: 1-12.
47. Peterlin BM, Price DH. 2006. Controlling the elongation phase of transcription with P-TEFb. Mol Cell 23: 297-305.
48. Preker P, Almvig K, Christensen MS, Valen E, Mapendano CK, Sandelin A, Jensen TH. 2011. PROMoter uPstream Transcripts share characteristics with mRNAs and are produced upstream of all three major types of mammalian promoters. Nucleic Acids Res 39: 7179-7193.
49. Proudfoot NJ. 2012. Ending the message: Poly(A) signals then and now. Genes Dev 25: 1770-1782.
50. Qi LS, Larson MH, Gilbert LA, Doudna JA, Weissman JS, Arkin AP, Lim WA. 2013. Repurposing CRISPR as an RNA-guided platform for sequence-specific control of gene expression. Cell 152: 1173-1183.
51. Rahl PB, Lin CY, Seila AC, Flynn RA, McCuine S, Burge CB, Sharp PA, Young RA. 2010. c-Myc regulates transcriptional pause release. Cell 141: 432-445.
52. Schroeder SC, Schwer B, Shuman S, Bentley D. 2000. Dynamic association of capping enzymes with transcribing RNA polymerase II. Genes Dev 14: 2435-2440.
53. Schwer B, Shuman S. 2011. Deciphering the RNA polymerase II CTD code in fission yeast. Mol Cell 43: 311-318.
54. Shi Y, Di Giammartino DC, Taylor D, Sarkeshik A, Rice WJ, Yates JR 3rd, Frank J, Manley JL. 2009. Molecular architecture of the human pre-mRNA 39 processing complex. Mol Cell 33: 365-376.
55. Tian B, Graber JH. 2012. Signals for pre-mRNA cleavage and polyadenylation. Wiley Interdiscip Rev RNA 3: 385-396.
56. Wang H, Yang H, Shivalila CS, Dawlaty MM, Cheng AW, Zhang F, Jaenisch R. 2013. One-step generation of mice carrying mutations in multiple genes by CRISPR/Cas-mediated genome engineering. Cell 153: 910-918.
57. West S, Proudfoot NJ. 2009. Transcriptional termination enhances protein expression in human cells. Mol Cell 33: 354-364.
58. Whitelaw E, Proudfoot N. 1986. α-Thalassaemia caused by a poly(A) site mutation reveals that transcriptional termination is linked to 39 end processing in the human α2 globin gene. EMBO J 5: 2915-2922.
59. Zhao J, Hyman L, Moore C. 1999. Formation of mRNA 39 ends in eukaryotes: Mechanism, regulation, and interrelationships with other steps in mRNA synthesis. Microbiol Mol Biol Rev 63: 405-445.